Triple negative breast cancer (TNBC) is a subtype of breast cancer where there is reduced expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) receptor. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.